Neuropeptide Y Is an Immunomodulatory Factor: Direct and Indirect. 2020

Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
Department of Anesthesiology, The Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.

Neuropeptide Y (NPY), which is widely distributed in the nervous system, is involved in regulating a variety of biological processes, including food intake, energy metabolism, and emotional expression. However, emerging evidence points to NPY also as a critical transmitter between the nervous system and immune system, as well as a mediator produced and released by immune cells. In vivo and in vitro studies based on gene-editing techniques and specific NPY receptor agonists and antagonists have demonstrated that NPY is responsible for multifarious direct modulations on immune cells by acting on NPY receptors. Moreover, via the central or peripheral nervous system, NPY is closely connected to body temperature regulation, obesity development, glucose metabolism, and emotional expression, which are all immunomodulatory factors for the immune system. In this review, we focus on the direct role of NPY in immune cells and particularly discuss its indirect impact on the immune response.

UI MeSH Term Description Entries
D007109 Immunity Nonsusceptibility to the invasive or pathogenic effects of foreign microorganisms or to the toxic effect of antigenic substances. Immune Process,Immune Response,Immune Processes,Immune Responses,Process, Immune,Response, Immune
D009478 Neuropeptide Y A 36-amino acid peptide present in many organs and in many sympathetic noradrenergic neurons. It has vasoconstrictor and natriuretic activity and regulates local blood flow, glandular secretion, and smooth muscle activity. The peptide also stimulates feeding and drinking behavior and influences secretion of pituitary hormones. Neuropeptide Y-Like Immunoreactive Peptide,Neuropeptide Tyrosine,Neuropeptide Y Like Immunoreactive Peptide,Tyrosine, Neuropeptide
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001831 Body Temperature The measure of the level of heat of a human or animal. Organ Temperature,Body Temperatures,Organ Temperatures,Temperature, Body,Temperature, Organ,Temperatures, Body,Temperatures, Organ
D004644 Emotions Those affective states which can be experienced and have arousing and motivational properties. Feelings,Regret,Emotion,Feeling,Regrets
D004734 Energy Metabolism The chemical reactions involved in the production and utilization of various forms of energy in cells. Bioenergetics,Energy Expenditure,Bioenergetic,Energy Expenditures,Energy Metabolisms,Expenditure, Energy,Expenditures, Energy,Metabolism, Energy,Metabolisms, Energy
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D056747 Immunomodulation Alteration of the immune system or of an immune response by agents that activate or suppress its function. This can include IMMUNIZATION or administration of immunomodulatory drugs. Immunomodulation can also encompass non-therapeutic alteration of the immune system effected by endogenous or exogenous substances. Immunomodulatory Therapy,Immunomodulations,Immunomodulatory Therapies,Therapies, Immunomodulatory,Therapy, Immunomodulatory

Related Publications

Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
April 2016, European journal of pharmacology,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
January 1985, Peptides,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
March 1991, Brain, behavior, and immunity,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
February 2011, Brain research,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
October 2008, FEBS letters,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
November 2017, Developmental and comparative immunology,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
April 2001, Nature,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
January 2016, Scientific reports,
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
January 1998, Advances in pharmacology (San Diego, Calif.),
Wei-Can Chen, and Yi-Bin Liu, and Wei-Feng Liu, and Ying-Ying Zhou, and He-Fan He, and Shu Lin
January 2024, European journal of heart failure,
Copied contents to your clipboard!